Pharmafile Logo

In-person, hybrid, or digital? State of Pharma meetings and events in 2024

March 18, 2024 |  

We’re diving into the state of pharmaceutical meetings and events in 2024 and–once and for all–put the idea of in-person meetings being superior to rest.

- PMLiVE

Whether we’re talking offices, medical congresses, or advisory board meetings, the term “hybrid” is often used to signal the ideal state. The place where everyone’s needs are being met. The best of both worlds. In the era of digital transformation, it is predicted that 2024 will be the year that finally cements hybrid meetings as the norm (1), with all-virtual meetings continuing to be a popular option. Yet, some people are holding onto the idea of in-person meetings being superior. In this article, we’re diving into the state of pharmaceutical meetings and events in 2024 and–once and for all–put this idea to rest.

Why in-person-only should be a thing of the past

I’ve written and talked about the blindspots of in-person meetings for over 16 years now, but it’s only been in the past few years that the benefits of virtual engagements have gained mainstream acceptance. There are multiple reasons why in-person-only meetings should be laid to rest, including, but not limited to, the facts that they are:

  • Expensive
  • Associated with a large environmental footprint
  • Inflexible and not accommodating to everyone’s schedules, work or personal commitments, and preferences
  • Susceptible to last-minute no-shows due to flight delays or poor driving conditions

Specifically for advisory boards and other insight-gathering initiatives, the in-person-only approach comes with additional pain points such as:

  • Valuable time wasted on didactic data presentations
  • Very limited “air time” per participant
  • Uneven share of voice, with more extroverted or senior advisors tending to take up more speaking time
  • A tendency for answers to be “knee-jerk reactions” rather than thought-through responses and for people to simply ‘agree’ with others
  • Limited ability to dive deeper into interesting or controversial ideas
  • Suboptimal diversity of advisors due to potential geographic or language barriers

Most important, though, is the fact that participants don’t want only in-person meetings. Based on our survey of hundreds of healthcare provider advisors in 2022–2023, over three-quarters stated that they prefer virtual/hybrid meetings, with the convenience and flexibility of digital meetings rated as the top benefits…

[Read the full article here]

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

See What’s Shaping Pharma Education in 2025: Join Our Free Webinar

From AI to VR, and everything in between—explore the cutting-edge tools revolutionizing medical training. Learn why these advancements are crucial for maintaining standards and excelling in the rapidly evolving landscape...

Optimizing Team Meetings in Remote Work – Building Company Culture Virtually

Rethink your approach to team meetings in a remote setting. Discover strategies for balancing synchronous and asynchronous communications to maximize decision-making and minimize meeting fatigue. Explore our tips for structuring...

Recreating the Onsite Experience with the Right Tools – Building Company Culture Virtually

Distance shouldn't hinder collaboration! This video explores how the right technology can bridge the physical gap and recreate the vibrant atmosphere of an in-office environment for your remote team in...

Defining the “Why” in Virtual Team Settings – Building Company Culture Virtually

Defining your team's purpose in a virtual setting is crucial for success. Are your workflows clear and documentation accessible? Learn how these elements can transform team dynamics and boost productivity,...

Establishing Remote Work Norms – Building Company Culture Virtually

Ready to redefine remote work in pharma? The second step is establishing clear norms, processes, and expectations that resonate with your team. Dive into our series for more tips on...

New Webinar: The 2025 Pharma Toolkit for Virtual Medical Education

Elevate your MedEd strategy with our 2025 toolkit! From AI-driven patient avatars to interactive augmented reality scenarios, learn about the hottest new virtual tools that are setting the standard for...

Scientific Workshop & Consensus Paper Development: A Customer Story

Launching in a complex market? See how virtual tools can streamline consensus-building and optimize treatment planning in our latest customer story. Discover how we helped endocrinology KOLs achieve consensus on...

Don’t miss out! Get a Sneak Peek at Next-Gen Life Science Education and Training Tools

From interactive case studies to AI-driven avatars, our free webinar dives into the tools defining tomorrow’s life sciences education. Last spots available – sign up now!

Infographic: Advantages & Disadvantages of Different Meeting Formats

Discover the unique pros and cons of in-person, hybrid, synchronous virtual, and asynchronous virtual meetings with our detailed infographic. Perfect for anyone planning efficient and engaging meetings, especially in pharmaceutical...

Pharma-exclusive Webinar: Next-gen Virtual Tools for Education & Learning in the Life Sciences

Unlock the potential of next-gen virtual tools in our upcoming webinar. From AI simulations to interactive AR booths, learn how to effectively apply these technologies in life sciences education and...